Key Events This Week
7 Sep: Intraday high surge to Rs.891.60 (+7.72%)
8 Sep: Valuation shifts to very expensive with Mojo Grade upgraded to Hold
11 Sep: Week closes at Rs.903.85 (-1.62% on day)

Supriya Lifescience Ltd is Rated Hold
2026-09-12 10:10:26Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Supriya Lifescience Ltd Valuation Shifts Signal Changing Market Sentiment
2026-09-08 08:01:15Supriya Lifescience Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, even as its stock price surged by 6.45% on 8 Sep 2026. This change reflects evolving market perceptions amid robust returns that have outpaced the broader Sensex over multiple time horizons.
Read full news article
Supriya Lifescience Ltd Surges 7.72% to Day's High of Rs 891.6 — Outperforms Sector by 4.25 Percentage Points
2026-09-07 09:33:00The Sensex declined 0.26% on 7 Sep 2026, while Supriya Lifescience Ltd surged 7.72%, marking a 4.25 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong single-session gain stands out amid a broadly weak market backdrop, signalling a stock-specific momentum shift rather than a general market rally.
Read full news articleSupriya Lifescience Gains 6.40%: Technical Momentum and Mixed Financials Shape the Week
2026-09-05 12:00:48
Key Events This Week
31 Aug: Technical momentum shifts amid mixed indicator signals
1 Sep: Upgraded to Hold as technicals improve despite mixed financials
4 Sep: Week closes at Rs.855.20, up 6.40% for the week

Supriya Lifescience Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials
2026-09-01 08:57:08Supriya Lifescience Ltd has seen its investment rating upgraded from Sell to Hold as of 31 August 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent quarterly setbacks, the company’s strong management efficiency, net-debt-free status, and growing institutional participation have contributed to a more balanced outlook for investors.
Read full news article
Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-08-31 08:03:02Supriya Lifescience Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals that investors should carefully analyse.
Read full news articleSupriya Lifescience’s Technical Shift and Downgrade Weigh on Stock Despite Long-Term Strength
2026-08-29 11:02:29
Key Events This Week
24 Aug: Stock opens at Rs.797.00, declines 0.99%
25 Aug: Downgrade to Sell announced; stock falls 0.72%
26 Aug: Technical momentum shift noted; stock drops 1.06%
27 Aug: Continued weakness; stock declines 0.86%
28 Aug: Strong recovery; stock surges 3.55%

Supriya Lifescience Downgraded to Sell Amid Technical and Financial Setbacks
2026-08-26 08:29:55Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 Aug 2026. This change reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation concerns despite some positive quality metrics and institutional interest.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11-Sep-2026 | Source : BSEIntimation of Investor/ Analyst Call is enclosed herewith.
Announcement under Regulation 30 (LODR)-Newspaper Publication
02-Sep-2026 | Source : BSECopy of Newspaper Public for dispatch of AGM Notice and Annual Report.
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015.
02-Sep-2026 | Source : BSEEnclosed herewith disclosure under Regulation 30.
Corporate Actions
No Upcoming Board Meetings
Supriya Lifescience Ltd has declared 50% dividend, ex-date: 04 Sep 26
No Splits history available
No Bonus history available
No Rights history available






